Diabetes Patients Turn to Open Source Software as Regulatory Lag Hinders Innovation

By Dana P. Goldman · STAT News · 2026-08-04

According to STAT News, some patients with type 1 diabetes are opting for unregulated, open-source code to manage insulin delivery because traditional devices approved by the FDA fail to keep pace with technological advancements. This shift toward homegrown software highlights a

According to STAT News, some patients with type 1 diabetes are opting for unregulated, open-source code to manage insulin delivery because traditional devices approved by the FDA fail to keep pace with technological advancements. This shift toward homegrown software highlights a